Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
342.5 GBX | -0.72% | -2.84% | -2.84% |
Mar. 13 | BTIG Adjusts Price Target on MaxCyte to $8 From $10, Maintains Buy Rating | MT |
Mar. 13 | MaxCyte loss widens in 2023 as core revenue declines 25% | AN |
Financials (USD)
Sales 2024 * | 34.23M | Sales 2025 * | 45.52M | Capitalization | 451M |
---|---|---|---|---|---|
Net income 2024 * | -51M | Net income 2025 * | -45M | EV / Sales 2024 * | 8.12 x |
Net cash position 2024 * | 173M | Net cash position 2025 * | 143M | EV / Sales 2025 * | 6.77 x |
P/E ratio 2024 * |
-8.71
x | P/E ratio 2025 * |
-10.4
x | Employees | 143 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.76% |
Latest transcript on MaxCyte, Inc.
1 day | -0.72% | ||
1 week | -2.84% | ||
Current month | -5.52% | ||
1 month | -5.52% | ||
3 months | -2.84% | ||
6 months | +37.00% | ||
Current year | -2.84% |
Managers | Title | Age | Since |
---|---|---|---|
Maher Masoud
CEO | Chief Executive Officer | 49 | - |
Douglas Swirsky
DFI | Director of Finance/CFO | 54 | 23-03-26 |
James Brady
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Balthrop
BRD | Director/Board Member | 67 | 22-11-30 |
Art Mandell
BRD | Director/Board Member | 71 | 06-04-30 |
Will Brooke
BRD | Director/Board Member | 68 | 04-02-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 12 M€ | -.--% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 342.5 | -0.72% | 19,524 |
24-03-27 | 345 | 0.00% | 16,722 |
24-03-26 | 345 | 0.00% | 25,720 |
24-03-25 | 345 | -2.13% | 7,184 |
24-03-22 | 352.5 | 0.00% | 96,280 |
Delayed Quote London S.E., March 28, 2024 at 12:35 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.84% | 451M | |
+9.50% | 222B | |
+7.95% | 185B | |
+18.30% | 141B | |
+18.47% | 100B | |
+7.83% | 68.36B | |
+25.32% | 57.52B | |
-3.69% | 46.84B | |
+4.66% | 42.64B | |
+15.12% | 29.09B |